Barclays Maintains Overweight on MetLife, Raises Price Target to $97

Benzinga Newsdesk www.benzinga.com Positive 68.4%

Neg 0% Neu 0% Pos 68.4%

Barclays analyst Alex Scott maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $94 to $97.

Comments

No comments yet. Be the first!